From a prognostic perspective, downregulation in metastatic melanoma tissues of these hub genes (KRT5, KRT6A, KRT6B, KRT10, KRT16, FLG, DSP, SPRR1B, PI3, and S100A7) revealed an unfavorable prognosis. This evidence concerns the gene KRT16 and melanoma.